💨 Abstract

Indian pharmaceutical experts anticipate collaboration with the US in healthcare security and affordability, as these are priorities for the new Trump Administration. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, believes that India and the US can collaborate to strengthen their pharmaceutical supply chains and advance healthcare.

Courtesy: theprint.in